TR199700782T1 - Interstisyel sistisin tedavisi i�in hiyaluronik asidin kullan�m�. - Google Patents

Interstisyel sistisin tedavisi i�in hiyaluronik asidin kullan�m�.

Info

Publication number
TR199700782T1
TR199700782T1 TR97/00782T TR9700782T TR199700782T1 TR 199700782 T1 TR199700782 T1 TR 199700782T1 TR 97/00782 T TR97/00782 T TR 97/00782T TR 9700782 T TR9700782 T TR 9700782T TR 199700782 T1 TR199700782 T1 TR 199700782T1
Authority
TR
Turkey
Prior art keywords
treatment
hyaluronic acid
cysticin
interstitial
intermittent
Prior art date
Application number
TR97/00782T
Other languages
English (en)
Turkish (tr)
Inventor
Morales Alvaro
Alkemade Stanley
Original Assignee
Bioniche Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/388,038 external-priority patent/US5591724A/en
Application filed by Bioniche Inc. filed Critical Bioniche Inc.
Publication of TR199700782T1 publication Critical patent/TR199700782T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
TR97/00782T 1995-02-14 1996-02-14 Interstisyel sistisin tedavisi i�in hiyaluronik asidin kullan�m�. TR199700782T1 (xx)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/388,038 US5591724A (en) 1995-02-14 1995-02-14 Method for treating the urinary bladder and associated structures using hyaluronic acid
US59101596A 1996-02-08 1996-02-08

Publications (1)

Publication Number Publication Date
TR199700782T1 true TR199700782T1 (xx) 1998-03-21

Family

ID=27012116

Family Applications (1)

Application Number Title Priority Date Filing Date
TR97/00782T TR199700782T1 (xx) 1995-02-14 1996-02-14 Interstisyel sistisin tedavisi i�in hiyaluronik asidin kullan�m�.

Country Status (20)

Country Link
US (1) US5888986A (d)
EP (1) EP0813417B1 (d)
JP (1) JP4354528B2 (d)
KR (1) KR100268660B1 (d)
CN (1) CN1181016A (d)
AT (1) ATE247476T1 (d)
AU (1) AU705289B2 (d)
BR (1) BR9607601A (d)
CA (1) CA2203621C (d)
CZ (1) CZ288218B6 (d)
DE (1) DE69629553T2 (d)
DK (1) DK0813417T3 (d)
ES (1) ES2205013T3 (d)
HU (1) HUP9800467A3 (d)
IN (1) IN181358B (d)
NO (1) NO315842B1 (d)
NZ (1) NZ300903A (d)
PT (1) PT813417E (d)
TR (1) TR199700782T1 (d)
WO (1) WO1996025168A1 (d)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6475795B1 (en) 1991-07-03 2002-11-05 Meditech Research, Ltd. Use of hyaluronan in gene therapy
US6548487B2 (en) 1996-12-27 2003-04-15 Seikagaku Corporation Agent for treatment of bladder troubles
US6232301B1 (en) 1996-12-27 2001-05-15 Seikagaku Corporation Remedies for bladder disorders
CA2347110C (en) * 1998-10-22 2008-08-26 Bioniche Life Sciences Inc. A method for preventing, reducing, and treating radiation cystitis using hyaluronic acid
US6083933A (en) * 1999-04-19 2000-07-04 Stellar International Inc. Treatment of cystitis-like symptoms with chondroitin sulfate following administration of a challenge solution
ES2288883T3 (es) * 1999-12-13 2008-02-01 Bioniche Life Sciences Inc. Oligonucleotidos sinteticos utiles terapeuticamente.
JP4215429B2 (ja) * 1999-12-28 2009-01-28 バイオニケ ライフ サイエンシーズ インコーポレイテッド 癌治療におけるヒアルロン酸
US7504387B2 (en) * 2002-10-16 2009-03-17 Arthrodynamic Technologies, Animal Health Division, Inc. Glycosaminoglycan composition and method for treatment and prevention of interstitial cystitis
US20040161476A1 (en) 2003-02-19 2004-08-19 Hahn Sungtack Samuel Cystitis treatment with high dose chondroitin sulfate
RU2270678C1 (ru) * 2004-06-30 2006-02-27 Государственное образовательное учреждение высшего профессионального образования Российский государственный медицинский университет Министерства здравоохранения Российской Федерации Способ лечения хронического цистита у детей
WO2006076663A2 (en) * 2005-01-14 2006-07-20 Urigen, Inc. Kits and improved compositions for treating lower urinary tract
DE102006060953A1 (de) * 2006-12-12 2008-08-07 Farco-Pharma Gmbh Pharmazeutische Zubereitung für die Behandlung entzündlicher Erkrankungen des Urogenitaltraktes
US8343942B2 (en) * 2008-04-04 2013-01-01 University Of Utah Research Foundation Methods for treating interstitial cystitis
TWI516269B (zh) 2009-08-14 2016-01-11 禾伸堂生技股份有限公司 使用於炎症性腸疾病（ｉｂｄ）治療和預防之透明質酸混合物
TWI383796B (zh) 2009-08-14 2013-02-01 Holy Stone Healthcare Co Ltd Use of hyaluronic acid mixture for the treatment and prevention of peptic ulcer and duodenal ulcer
HUP0900717A3 (en) * 2009-11-18 2012-02-28 Richter Gedeon Nyrt Pharmaceutical composition for urological use containing zinc hyaluronate
US20110166098A1 (en) * 2010-01-04 2011-07-07 Wu Tsung-Chung Mixture of hyaluronic acid for treating and preventing inflammatory bowel disease
US8722644B2 (en) 2010-01-04 2014-05-13 Holy Stone Healthcare Co., Ltd. Mixture of hyaluronic acid for treating and preventing peptic ulcer and duodenal ulcer
US8575130B2 (en) * 2010-01-04 2013-11-05 Holy Stone Healthcare Co., Ltd. Mixture of hyaluronic acid for treating and preventing inflammatory bowel disease
US8449512B2 (en) 2010-04-09 2013-05-28 Davinci Biomedical Research Products Inc. Stoma stabilitating device and method
US9029347B2 (en) 2010-08-05 2015-05-12 Holy Stone Healthcare Co., Ltd. Method and mixture for treating and preventing inflammatory bowel disease
ES2665254T3 (es) * 2011-07-12 2018-04-25 Holy Stone Healthcare Co., Ltd. Composiciones que comprenden ácido hialurónico para tratamiento y prevención de enfermedades relacionadas con las mucosas
ITMI20111732A1 (it) * 2011-09-27 2013-03-28 Bsdpharma Srl Formulazioni farmaceutiche per la riduzione della sensibilizzazione crociata tra colon-retto ed il distretto urogenitale con mezzi non-farmacologici.
RU2519010C1 (ru) * 2013-03-20 2014-06-10 Общество с ограниченной ответственностью "КОЛЕТЕКС" Композиция для лечения цистита
WO2015018461A1 (fr) 2013-08-09 2015-02-12 Genbiotech Compositions therapeutiques comprenant d'acide hyaluronique
CN103655601B (zh) * 2013-12-31 2019-10-25 上海建华精细生物制品有限公司 一种用于膀胱灌洗的组合物
CN103861091B (zh) * 2014-03-20 2016-04-27 辽宁亿灵科创生物医药科技有限公司 治疗膀胱炎的药物组合物
WO2015154007A1 (en) * 2014-04-03 2015-10-08 Lipella Pharmaceuticals, Inc. Systems and methods of detecting interstitial cystitis
US20160045623A1 (en) 2015-04-03 2016-02-18 Lipella Pharmaceuticals, Inc. Systems and Methods to Image Intercellular and Intercompartmental Defects with Magnetic Resonance Imaging (MRI)
RU2557949C1 (ru) * 2014-08-14 2015-07-27 Общество с ограниченной ответственностью "КОЛЕТЕКС" Способ лечения лучевого и интерстициального цистита
GB201616838D0 (en) * 2016-10-04 2016-11-16 Nat Univ Ireland Hyaluronan compositions, and uses thereof in treatment of interstitial cystitis
EP3400951B1 (de) * 2017-05-12 2019-12-11 Farco-Pharma GmbH Blaseninstillationszusammensetzung enthaltend chondoitinsulfat (4,5 mg/ml), hyaluronsäure (16 mg/ml) und phosphatpuffer (ph 6,1 bis 7,9) mit erhöhter lagerstabiliät zur behandlung von cystitis
IT201900019762A1 (it) * 2019-10-24 2021-04-24 Fidia Farm Spa Composizione farmaceutica per uso nel trattamento della cistite di varia eziologia

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141973A (en) * 1975-10-17 1979-02-27 Biotrics, Inc. Ultrapure hyaluronic acid and the use thereof
US4296104A (en) * 1979-08-30 1981-10-20 Herschler R J Therapeutic dimethyl sulfoxide composition and methods of use
US4302577A (en) * 1979-10-05 1981-11-24 Biomed Research Inc. Process for preparing CSA or CSC
US5180715A (en) * 1980-11-17 1993-01-19 The Regents Of The University Of California Irrigation of internal bladder surfaces in mammals with sodium pentosanpolysulfate
DE3118588C2 (de) * 1981-05-11 1983-07-07 Luitpold-Werk, Chemisch-Pharmazeutische Fabrik, 8000 München Verfahren zur Herstellung eines injizierbaren hochreinen Chondroitinpolysulfates, hiernach erhältliches Produkt und pharmazeutische Zusammensetzung
US4640912A (en) * 1983-06-09 1987-02-03 Hausman Marvin S Administration of "active" chondroitin sulfate A and "active" chondroitin sulfate C or mixtures thereof to mammals including humans
US4711780A (en) * 1984-06-11 1987-12-08 Fahim Mostafa S Composition and process for promoting epithelial regeneration
US4820693A (en) * 1986-05-22 1989-04-11 Angiogenics, Ltd. Method and composition for arresting angiogenesis and capillary, cell or membrane leakage
US4966890A (en) * 1986-04-04 1990-10-30 Angiogenics, Ltd. Method and composition for arresting angiogenesis and capillary, cell or membrane leakage
US5037810A (en) * 1987-03-17 1991-08-06 Saliba Jr Michael J Medical application for heparin and related molecules
US4879282A (en) * 1987-03-17 1989-11-07 Saliba Jr Michael J Medical application for heparin and related molecules
ES2150427T3 (es) * 1992-06-02 2000-12-01 Bard Inc C R Procedimiento y dispositivo de implante para el suministro de farmacos a largo plazo.
US5633001A (en) * 1993-03-19 1997-05-27 Medinvent Composition and a method for tissue augmentation

Also Published As

Publication number Publication date
HUP9800467A2 (hu) 1998-06-29
NZ300903A (en) 1999-07-29
CZ257497A3 (cs) 1998-01-14
MX9706182A (es) 1998-07-31
ES2205013T3 (es) 2004-05-01
BR9607601A (pt) 1999-09-14
AU4617996A (en) 1996-09-04
CZ288218B6 (en) 2001-05-16
PT813417E (pt) 2003-12-31
KR19980702251A (ko) 1998-07-15
CA2203621A1 (en) 1996-08-22
HUP9800467A3 (en) 1999-01-28
DE69629553T2 (de) 2004-06-17
NO315842B1 (no) 2003-11-03
DK0813417T3 (da) 2003-11-03
US5888986A (en) 1999-03-30
JP4354528B2 (ja) 2009-10-28
KR100268660B1 (ko) 2000-10-16
NO973732L (no) 1997-10-10
IN181358B (d) 1998-05-30
ATE247476T1 (de) 2003-09-15
CA2203621C (en) 1998-04-28
AU705289B2 (en) 1999-05-20
JPH10513476A (ja) 1998-12-22
DE69629553D1 (de) 2003-09-25
EP0813417A1 (en) 1997-12-29
EP0813417B1 (en) 2003-08-20
NO973732D0 (no) 1997-08-13
WO1996025168A1 (en) 1996-08-22
CN1181016A (zh) 1998-05-06

Similar Documents

Publication Publication Date Title
TR199700782T1 (xx) Interstisyel sistisin tedavisi i�in hiyaluronik asidin kullan�m�.
ATE300298T1 (de) Behandlung von leukocyten durch photopheresis
DE3765146D1 (de) Vernetzte karboxylgruppen enthaltende kopolymere, verwendbar als verdickungsmittel in waessrigen systemen und deren herstellung.
PT781092E (pt) Metodo de sensibilizacao de celulas tumorais utilizando adenovirus e1a
DE69713335D1 (de) Polymere zur abgabe von stickstoffoxide in vivo
ATE91411T1 (de) Vermehrte herstellung von mit liposomen eingekapseltem haemoglobin.
BR9910251A (pt) Estimulação hematopoiética
FR2715844B1 (fr) Emulsion contenant de l'acide ascorbique stabilisé, procédé de traitement cosmétique la mettant en Óoeuvre, ses utilisations.
ES2063478T3 (es) Polisiloxanos de urea insaturados.
DE59608422D1 (de) Verfahren zur Herstellung von Poly(diorganosiloxanen), Mischungen, enthaltend diese Poly(diorganosiloxane) und deren Verwendung
PT83825A (de) Mittel zur bestimmung von peroxidase-aktivitaet mit stabilisator verfahren zur herstellung und seine verwendung
IE42686L (en) Perfume carriers based on polyurethane-polyurea gels
DE3579194D1 (de) Neoalkoxy organo-titanate und organo-zirkonate nuetzlich als kuppler und polymerbehandlungsagenzien.
ATE41270T1 (de) Ionenleitendes polymeres material und verfahren zu seiner herstellung.
ATE230613T1 (de) Polymere platinverbindungen
KR880001769A (ko) 유리 섬유제품 처리제
KR850008195A (ko) 섬유처리제 및 그를 사용한 섬유처리방법
DE3777486D1 (de) Hydroperoxydierte poly-n-vinyllactam-teilchen, verfahren und verwendung davon.
ATE41675T1 (de) Immobilisierung von katalytisch aktiven mirkoorganismen in agargelfasern.
DE3673768D1 (de) Mittel zur bestimmung von peroxidase-aktivitaet, verfahren zur herstellung und seine verwendung.
ATE246254T1 (de) Verwendung von oxidationsfördernden chemikalien für die oxidation von einem polymer, das die alkoholkonfiguration eines oxidierbaren galaktosetyps enthält.
DE69600367D1 (de) Verwendung von Sulfasalazin und/oder dessen aktiven Metaboliten zur Herstellung eines Arzneimittels zur Behandlung von venöser Insuffizienz und venösen Ulcera
ES8800283A1 (es) Un procedimiento para aumentar la duracion de "vitalidad" en polimero vivos obtenidos por polimerizacion catalizada por oxianiones.
SU1078894A1 (ru) Способ получения гемосовместимых полимерных гидрогелей
JPS6462301A (en) Production of substance having gelling ability